<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">SCD</journal-id><journal-title-group><journal-title>Stem Cell Discovery</journal-title></journal-title-group><issn pub-type="epub">2161-6760</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/scd.2015.51001</article-id><article-id pub-id-type="publisher-id">SCD-52959</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  An Insight on Small Molecule Induced Foot-Print Free Naive Pluripotent Stem Cells in Livestock
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>engmei</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lanyu</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Vinod</surname><given-names>Verma</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Qingyou</surname><given-names>Liu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Deshun</surname><given-names>Shi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ben</surname><given-names>Huang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jun</surname><given-names>Zhang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangxi University, Nanning, China</addr-line></aff><aff id="aff3"><addr-line>Centre of Biotechnology, Nehru Science Centre, University of Allahabad, Allahabad, India</addr-line></aff><aff id="aff1"><addr-line>School of Animal Science and Technology, Guangxi University, Nanning, China</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>deshunshi@gxu.edu.cn(DS)</email>;<email>arihuangben@yahoo.com(BH)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>01</month><year>2015</year></pub-date><volume>05</volume><issue>01</issue><fpage>1</fpage><lpage>9</lpage><history><date date-type="received"><day>29</day>	<month>October</month>	<year>2014</year></date><date date-type="rev-recd"><day>27</day>	<month>November</month>	<year>2014</year>	</date><date date-type="accepted"><day>18</day>	<month>December</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Bona fide embryonic stem cell (ESC) lines from livestock species have been challenging to derive and maintain, contrasting mouse and human ESCs. However, induced pluripotent stem cells (iPSC) generated by reprogramming somatic cells tender an option, as they display characteristic features of ESC. The comprehension that induced pluripotent stem cells (iPSC) could be created with in no time also holds the potential of allowing pluripotent cells to be derived from animal models vital in biomedical research. Endeavors to produce bona fide pluripotent stem cells (PSC) from livestock have been going on for more than two decades. But, attempts to derive bona fide livestock iPS cells have met with limited success. Recently it’s been reported that small molecules can augment reprogramming efficiency and may be used to substitute few or all transcription factors used for reprogramming. It is assumed that the reprogramming factors are conserved among species, and this small molecule reprogramming approach will probably apply to livestock species as well. So this review will focus mainly on the accomplishments of small molecules on accelerating cell reprogramming and obtaining naive pluripotency, and raise a new insight on, exogenous genes free, livestock naive iPSC generation with a new bullet, small molecule.
 
</p></abstract><kwd-group><kwd>Small Molecule</kwd><kwd> Foot-Print Free</kwd><kwd> Naive Pluripotent Stem Cell</kwd><kwd> Livestock</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Naive pluripotent stem cell is defined by possessing pluripotent characteristic, expressing pluripotency marker gene, three germ layers in vitro and in vivo differentiation, especially, capable of forming germ-line chimera [<xref ref-type="bibr" rid="scirp.52959-ref1">1</xref>] - [<xref ref-type="bibr" rid="scirp.52959-ref3">3</xref>] . Pluripotent stem cells combined with embryos and transgenic animal technology, produced biomedical models, promoted animal breeding, genetic improvement of animal nature, and speed up the animal population genetic variation. And also it could break down the species barrier and kinship restrictions, overcome interspecific reproductive barriers, and acquire new traits which could not be obtained by traditional breeding methods. In addition, at the cellular level of embryos for early selection, it could improve the accuracy of selection, and shorten the breeding time [<xref ref-type="bibr" rid="scirp.52959-ref4">4</xref>] . Since livestock naive pluripotent stem cells had such important application prospects, in the past three decades, the researchers had been engaged in isolation and culture of those pluripotent stem cell, but were not fully successful [<xref ref-type="bibr" rid="scirp.52959-ref5">5</xref>] determined by not being able to capture naive fully pluripotent stage from embryos. With the advent of the induced pluripotent stem cells (iPSC) technology, by conducting some transcription factors into somatic cell, it could reactivate endogenous pluripotent related genes expression, and then transform somatic cell to pluripotent cell. Through this approach, in livestock, the pig, sheep, goat, cattle, horse, and buffalo iPSC had been reported [<xref ref-type="bibr" rid="scirp.52959-ref6">6</xref>] - [<xref ref-type="bibr" rid="scirp.52959-ref11">11</xref>] ; it holds great potential to successfully capture naive stage fully pluripotency in livestock. However, livestock iPSC technology platform still has two major barriers: 1) it had not achieved naive fully pluripotent iPSC. Almost all of the reported livestock iPSC were not capable to form germ line chimera [<xref ref-type="bibr" rid="scirp.52959-ref10">10</xref>] which is the gold standard assay for pluripotency, except one report where porcine iPSC were capable of forming the germ line chimera, though efficiency was low [<xref ref-type="bibr" rid="scirp.52959-ref12">12</xref>] ; 2) the integration of exogenous genes into the genome or not completely silent, might lead to carcinogenicity and oncogenes such as cmyc sustained expression that has potential to hamper downstream applications. Researcher has shown that iPSC with non-silenced exogenous gene significantly reduced the developmental capability of nuclear transfer embryos if used as a donor cell [<xref ref-type="bibr" rid="scirp.52959-ref13">13</xref>] .</p></sec><sec id="s2"><title>2. Induced Pluripotent Stem Cells (iPSC) Generation</title><p>Generation of a pluripotent state was only possible in case of cell fusion and somatic cell nuclear transfer [<xref ref-type="bibr" rid="scirp.52959-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref15">15</xref>] until discovery of induced pluripotency by Yamanaka at 2006. Four factors [Pou5f1, Sox2, Klf4 and C-myc] selected from 24 prospective genes known to play a role in pluripotency maintenance were capable of initiating an ESC-like state when transduced into somatic cells [<xref ref-type="bibr" rid="scirp.52959-ref16">16</xref>] . In 2012 Yamanaka won the Nobel Prize in physiology or medicine for his finding of how to transform ordinary somatic cell into cells that, like embryonic stem cells, have potential of developing into any cell in the human body. Until now iPSC had been generated from many species, such as the human, rat, rabbit, pig, sheep, goats, cattle, horse, and buffalo etc [<xref ref-type="bibr" rid="scirp.52959-ref6">6</xref>] - [<xref ref-type="bibr" rid="scirp.52959-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref17">17</xref>] - [<xref ref-type="bibr" rid="scirp.52959-ref19">19</xref>] . In recent years iPSC technology has become an important tool in the field of advanced biotechnology. This technique can be used in drug screening, cell therapy and organ transplantation, disease models [<xref ref-type="bibr" rid="scirp.52959-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref21">21</xref>] , animal breeding and transgenic animal production [<xref ref-type="bibr" rid="scirp.52959-ref22">22</xref>] , therefore the iPSC technology since the debut were pursued by scientists all over the world.</p></sec><sec id="s3"><title>3. Methods for iPSC Generation</title><p>Yamanaka [<xref ref-type="bibr" rid="scirp.52959-ref16">16</xref>] developed iPSC technology in 2006. Since then, based on this or modified protocol, researchers from various labs generated iPSC from different species. In humans by ectopic expression of transcription factors like, POU5F1, SOX2, KLF4 and C-MYC [<xref ref-type="bibr" rid="scirp.52959-ref17">17</xref>] , or SOX2, POU5F1, NANOG and LIN28, researchers successfully transformed human fibroblast cells into iPS cells [<xref ref-type="bibr" rid="scirp.52959-ref23">23</xref>] . Further, experimentation with cellular reprogramming has demonstrated that the only indispensible factors are POU5F1 and SOX2 [<xref ref-type="bibr" rid="scirp.52959-ref24">24</xref>] . However, use of NANOG, LIN28, C-MYC and KLF-4 greatly increased reprogramming efficiency. Since, the inception of iPSC technology, one parameter that remains constant is stimulation of pluripotent related endogenous gene expression [SOX2, NANOG, LIN28, POU5F1, KLF4 and C-MYC etc.] in order to reprogram somatic cell regardless of approaches. There are various methods to reprogram somatic cell and these can be categorized broadly into two categories: viral vector and non-viral vector methods.</p><sec id="s3_1"><title>3.1. Viral Vector Methods</title><p>Viral vector methods mainly include lentiviral and retrovirus vector method. Retroviral vectors were commonly used in previous research for iPSC generation, mainly used to infect actively dividing cells, but not non-dividing cells such as neurons [<xref ref-type="bibr" rid="scirp.52959-ref16">16</xref>] . The lentiviral vector could effectively infect dividing cells and non-dividing cells, and it was the most conventional approach to generate iPSC. The biggest advantage of viral vector method was relatively high transfection efficiency, which was effectively delivering exogenous genes into the cells. However, this method may cause the viral vector sequence and exogenous transcriptional factor sequence permanently integrated into the cell genome, and may cause the insertion mutagenesis, that might interfere with the normal iPSC function. Moreover, the expressions of residual exogenous factor even lead to the occurrence of cancer, which would be a potential safety problem. It severely limits the application of iPSC at basic research and clinical research. In order to avoid these problems, instead of the permanent integration, adenovirus vector was used to deliver exogenous gene by transient transcription to obtain iPS cells [<xref ref-type="bibr" rid="scirp.52959-ref25">25</xref>] . In this approach probability of viral integration into the host genome was less, but the reprogramming efficiency was poor.</p></sec><sec id="s3_2"><title>3.2. Non-Viral Vector Methods</title><p>Clinical application of iPSC generated by viral approach is limited by the fact that most protocols modify the genome to effect cellular reprogramming which carries the risk of insertion mutagenesis. So, there is a need to switch to non-integrating, non-viral strategies to reprogram somatic cells. Plasmid transfection is most commonly used non-viral vector method. This method could reduce the insertion of exogenous gene into host gemone. However, the transfection efficiency was relatively low, and the exogenous gene might be integrated into the cell genome or not completely silent [<xref ref-type="bibr" rid="scirp.52959-ref7">7</xref>] . Currently, researchers are using microRNA (Micro ribonucleic acid) induction method for virus and integration free mouse and human iPSC generation. However, livestock pluripotent stem cell regulation mechanism is not clear which is causing difficulty to use this method for iPSC generation in livestock [<xref ref-type="bibr" rid="scirp.52959-ref26">26</xref>] . But, this method still could not completely avoid the potential side-effect of exogenous micro RNA to host genome or intrinsic gene transcripting network. Even these commonly used methods are plagued with host genome integration issues. So the development of non-viral, non-integrating induction method has become a new hot spot for iPSC research. Kim et al., 2009 reported that applied recombination protein could completely circumvent the problems related with iPSC generation [<xref ref-type="bibr" rid="scirp.52959-ref27">27</xref>] , and they claimed that iPSC has been generated by only recombination proteins of OCT4, SOX2, KLF4 and CYMC. However, reprogramming efficiency in this method was very low, and since then there were not any reproducible report which indicates it has no applied value. Hou et al., 2013 results showed that mouse somatic cells could be induced into pluripotent stem cells by seven small molecular compounds [CiPSC] without any exogenous genes [<xref ref-type="bibr" rid="scirp.52959-ref28">28</xref>] . Using this transgene free approach, they demonstrated that CiPSC can be generated from mouse somatic cells with a frequency up to 0.2%. Those mice CiPSC were at naive pluripotency stage recognized by contribution to germ line transmission. Furthermore, chimeric mice with germ line transmission generated from CiPSCs were 100% viable and healthy. The utilization of small molecule compounds instead of exogenous gene is an ideal method to generate exogenous gene free and naive iPSC.</p></sec></sec><sec id="s4"><title>4. The Prospect of Livestock, Exogenous Gene Free, Naive Induced Pluripotent Stem Cells: Small Molecule Compounds</title><sec id="s4_1"><title>4.1. Small Molecule Compounds Promoted iPSC Reprogramming</title><p>At present, research results showed that small molecular compounds have a wide range of applications and significant effect to facilitate the study of iPSC reprogramming and related mechanism [<xref ref-type="bibr" rid="scirp.52959-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref30">30</xref>] . Through the screening of small molecule compounds, biological characteristics, cell fate, related signal pathway and its regulation mechanism of pluripotent stem cell could be clearly investigated and consequently obtaining fully pluripotent stem cells [<xref ref-type="bibr" rid="scirp.52959-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref31">31</xref>] . Effects of small molecules on iPSC programming mainly have two aspects: promoting the efficiency of fully reprogrammed cells and replacing transcription factor [<xref ref-type="bibr" rid="scirp.52959-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref31">31</xref>] .</p><p>According to the functional mechanism of small molecule compounds on iPSC, they could be divided into two main categories: 1) acting on the protein kinase of signalling pathway to manipulate related gene expression; 2) altering epigenetic landscape by directly affecting histone methylation, acetylation, and phosphorylation [<xref ref-type="bibr" rid="scirp.52959-ref31">31</xref>] . Small molecule compounds could significantly improve somatic cell reprogramming efficiency which has been verified by various reports on iPSC generation from human, mouse, rat, cattle and other species. The ALK inhibitor SB431542, MEK1/2 inhibitor PD0325901 enhanced the efficiency of human cell reprogramming up to 200 folds [<xref ref-type="bibr" rid="scirp.52959-ref32">32</xref>] . PD0325901 with Thiazovivin and SB431542 significantly increased reprogramming efficiency [79.5 - 200 times] in human fibroblasts transfected with four exogenous transcription factors [<xref ref-type="bibr" rid="scirp.52959-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref34">34</xref>] . Moreover, it also has shown improvement in bovine somatic cell reprogramming [<xref ref-type="bibr" rid="scirp.52959-ref35">35</xref>] . Histone deacetylase inhibitors [VPA and Sodium butyrate], DNA methyltransferase inhibitors (5-azacytidine, RG108 and BayK8644) significantly improved mouse and human cell reprogramming efficiency up to 20 - 50 times [<xref ref-type="bibr" rid="scirp.52959-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref36">36</xref>] - [<xref ref-type="bibr" rid="scirp.52959-ref38">38</xref>] . Xie Xin research group’s [<xref ref-type="bibr" rid="scirp.52959-ref39">39</xref>] studies showed that the LiCl by increasing the expression of Nanog and change of cell epigenetic modification, significantly increased the mouse somatic cell reprogramming efficiency up to 60 times. At 2013, they also found that the use of inhibitors of P53 could improve the cell reprogramming effective [<xref ref-type="bibr" rid="scirp.52959-ref40">40</xref>] . Current research results proposed that small molecule compound [CYT296] induced chromatin de-condensation and facilitated induced pluripotent stem cell generation. This novel small molecule could increase OSKM-me- diated iPSC induction more than 10 folds [<xref ref-type="bibr" rid="scirp.52959-ref41">41</xref>] .</p></sec><sec id="s4_2"><title>4.2. Small Molecule Compounds Replaced Transcription Factors for Reprogramming, and Contributed to Exogenous Gene Free iPSC</title><p>Currently, large number of studies have indicated that small molecule compounds can substitute related transcription factors for cell reprogramming, such as E-616452, LY-364947 inhibitors could replace transcription factor Sox2 on mouse fibroblasts reprogramming [<xref ref-type="bibr" rid="scirp.52959-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref43">43</xref>] . Mouse fibroblast cells transfected with Oct4, Sox2, c-Myc with the synergistic effects of Kenpaullone could be fully reprogrammed into iPS cells, showed that Kenpaullone substituted Klf4 reprogramming function [<xref ref-type="bibr" rid="scirp.52959-ref44">44</xref>] . The Melton’s team [<xref ref-type="bibr" rid="scirp.52959-ref45">45</xref>] by adding VPA converted somatic cell transfected with only two factors Oct4 and Sox2 into iPSC, which eliminates the requirement of oncogene c-Myc and Klf4 for iPSC generation. Ding’s team [<xref ref-type="bibr" rid="scirp.52959-ref36">36</xref>] also found that iPSC could be generated by ectopic expression of only two transcription factors i.e., Oct4 and Klf4, along with small molecules BIX-01294 and BayK8644. Also Sui et al., 2014 found that using small molecule trimethoprim [TMP] by engineering reprogramming factors to a destabilizing protein domain, they achieved inducible generation of mouse and pig iPSCs without exogenous OCT4 or KLF4 transduction [<xref ref-type="bibr" rid="scirp.52959-ref46">46</xref>] . Research further proved that using only one transcription factor, OCT4, combined with some small molecule compounds [valproic acid, CHIR99021, 616452, tranylcypromine] successfully reprogrammed mouse and human somatic cells into pluripotent stem cells [<xref ref-type="bibr" rid="scirp.52959-ref37">37</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref47">47</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref48">48</xref>] . Recently, Deng Hongkui research group’s finding showed that mouse somatic cells could be induced into naive pluripotent stem cells with small molecular compounds [CiPSC], without any exogenous gene application [<xref ref-type="bibr" rid="scirp.52959-ref28">28</xref>] . All these findings indicates that chemical induction approach holds the great potential for generating exogenous genes free iPSC from other species including livestock. However, until now, no progress has been made in livestock species similar to the reports as that of Hou et al., 2013. Kang et al., 2014 demonstrated that combinations of small molecules (oxysterol and purmorphamine) could compensate for all reprogramming factors and were sufficient to directly reprogram mouse somatic cells into naive-like iPSC as determined by non- germ line chimera forming ability [<xref ref-type="bibr" rid="scirp.52959-ref49">49</xref>] . We also screened small molecular compounds to establish our own induction system. Currently, our results showed that we had obtained mouse and goat CiPSC-like cells. Those cells formed 3D colonies with clear edge, and expressed certain pluripotentcy-related genes. Moreover, they also expressed three germ layer related marker genes while they were differentiated in vitro (2014, unpublished results). Partially, we have proved that iPSC could be generated by fully chemical approach without any exogenous gene. However, more experiments need to be done to determine whether those CiPSC-like cells were fully pluripotent. The above studies exploring the use of small molecule compounds on iPSC provided theoretical and technical basis to achieve exogenous gene free livestock naive iPSC.</p></sec><sec id="s4_3"><title>4.3. Small Molecule Compounds Maintained Pluripotent Stem Cell Self-Renewal and Conversed Primed to Naive Stage</title><p>Ying et al. reported that chemically defined medium supplemented with small molecule compounds [PD0325901 and CHIR99021] and LIF, named 2i/LIF medium [<xref ref-type="bibr" rid="scirp.52959-ref50">50</xref>] could support not only established mouse and human pluripotent stem cells lines [<xref ref-type="bibr" rid="scirp.52959-ref51">51</xref>] - [<xref ref-type="bibr" rid="scirp.52959-ref53">53</xref>] , but also pluripotent stem cell from other species, such as rats and mice of other strains, which were not able to survive and sustain in the traditional culture system. 3i/LIF culture medium including three inhibitors, CHIR99021, PD184352, and SU5402, led to the first isolation and establishment of bona fide ESCs from rat embryos [<xref ref-type="bibr" rid="scirp.52959-ref54">54</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref55">55</xref>] . Eventually, small molecules helped the researchers to capture naive pluripotent stem cell lines [<xref ref-type="bibr" rid="scirp.52959-ref56">56</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref57">57</xref>] . The small molecule PD0325901 inhibitor blocks the ERK phosphorylation in order to maintain undifferentiated state [<xref ref-type="bibr" rid="scirp.52959-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref58">58</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref59">59</xref>] , and at the same time, another small molecule CHIR99021 inhibits GSK3 activity, which facilitates the Wnt signaling pathway and it results in pluripotent stem cell self- renewal. Therefore, 2i/LIF promotes the self-renewal and maintains the pluripotency of stem cells. Adding other small molecular compounds [PD173074 and A-83-01] into 2i/LIF could convert primed stage pluripotent cells [mouse epiblast stem cell] to naive stage fully pluripotent stem cell [<xref ref-type="bibr" rid="scirp.52959-ref60">60</xref>] . Sodium butyrate efficiently converted fully reprogrammed [Naive] induced pluripotent stem cells from mouse partially reprogrammed [Primed] cells [<xref ref-type="bibr" rid="scirp.52959-ref61">61</xref>] . Using small molecule SB431542 [TGF-inhibitor] instead of CHIR99021 in 2i/LIF medium, significantly improves the efficiency of mouse embryonic stem cells generation from embryo [up to 100%], and also facilitates the retrieval of embryonic stem cell [ES] lines from other mouse strains which have not been established [<xref ref-type="bibr" rid="scirp.52959-ref62">62</xref>] . The recent studies [<xref ref-type="bibr" rid="scirp.52959-ref2">2</xref>] have showed that morphological and biological characteristics of human ES was more similar to the mouse primed epiblast stem cells [counterpart to primed state]. In order to obtain naive stage of human pluripotent stem cell similar to that of mouse ES cell, they used 2i/LIF culture system supplemented with other small molecules to culture human ES cell, and found that morphology of their colony turned into dome shape as similar as that of mouse ES from tiled monolayer cells. When naive human ES were injected into mouse embryo, germ-line transmission chimera mouse could be produced [<xref ref-type="bibr" rid="scirp.52959-ref2">2</xref>] . The outcome of the experiment proved that small molecule compounds could convert the stem cell from primed to naive state. The above research results showed that small molecule compounds were capable to effectively promote the pluripotent stem cell self-renewal and transformation from primed to naive pluripotency. It has opened a door for application of small molecule compounds on livestock pluripotent stem cells in order to achieve naive pluripotency.</p></sec><sec id="s4_4"><title>4.4. Small Molecule Compounds Supported Livestock Pluripotent Stem Cell in Vitro Culture</title><p>In the past 3 years, researcher attempted to use small molecule compounds for livestock pluripotent stem cells generation and culture, and there has been some progress. Nagy supplemented culture with several small molecular compounds [A83-01, Thiazovivin and SB431542] and transfected the horse fibroblast cells with reprogramming transcription factors. They were able to obtained horse iPSC cell lines for the first time, but did not confirmed whether the cells were fully pluripotent, naive stage [<xref ref-type="bibr" rid="scirp.52959-ref8">8</xref>] . Several reports suggested that small molecule inhibitors could be used in iPSC culture to increase the homogeneity, especially, pig iPSC [<xref ref-type="bibr" rid="scirp.52959-ref63">63</xref>] . Rodriguez [<xref ref-type="bibr" rid="scirp.52959-ref2012">2012</xref>], Zhang [<xref ref-type="bibr" rid="scirp.52959-ref2014">2014</xref>] and Gao [<xref ref-type="bibr" rid="scirp.52959-ref2014">2014</xref>], respectively, showed that using 2i/LIF medium would promote access to fully pluripotent porcine naive iPSC and its self-renewal [<xref ref-type="bibr" rid="scirp.52959-ref63">63</xref>] - [<xref ref-type="bibr" rid="scirp.52959-ref65">65</xref>] . Sharma showed that adding small molecular compounds Y-27632 or SU5402 into culture could promote the colony formation and maintain long-term culture of buffalo ES-like cell. However, he did not obtain chimeric buffalo [<xref ref-type="bibr" rid="scirp.52959-ref66">66</xref>] - [<xref ref-type="bibr" rid="scirp.52959-ref68">68</xref>] . In recent years, our results also showed that 2i/LIF medium had potential application prospect on bovine and other livestock pluripotent stem cells [ES/iPSC] [<xref ref-type="bibr" rid="scirp.52959-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref69">69</xref>] [<xref ref-type="bibr" rid="scirp.52959-ref70">70</xref>] . Our latest research results [<xref ref-type="bibr" rid="scirp.52959-ref71">71</xref>] shows that the use of GSK inhibitors in small molecule compounds CHIR and BIO would improve the buffalo ES-like cell colony formation rate and the proliferation potential. Therefore, through the further screening, some small molecule compounds are expected to be discovered to increase livestock iPSC reprogramming efficiency, replace all transcription factors and capture fully pluripotentcy in vitro, subsequently, exogenous gene free livestock naive iPSC will be obtained.</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>Naive pluripotent stem cells from ungulates could be used for the production of biomedical models and it will help in accelerating animal breeding. Still we do not have those naive state pluripotent stem cells but are much closer than ever before. Above all, a new bullet, small molecule compounds will be able to break through barriers by promoting iPSC reprogramming efficiency and self-renewal, converting primed to naive stage pluripotentcy, generating exogenous gene free chemically induced pluripotent stem cell from livestock. It is foreseeable that the interplay between iPSC technology and small molecule compounds will push forward the application of livestock iPSC-based biomedical model and animal breeding. At next step, research should be focused on analyzing the naive pluripotent stem cell related signaling pathway for maintaining pluripotency and converting primed to naive stage, then establishing a small molecule screening library. Subsequently, using high-throughput screening platform, small molecule compounds which could capture naive pluripotent stem cell in livestock will be selected. After procuring those selected small molecule compounds, we will be able to cross the barriers to achieve exogenous gene free naive pluripotent stem cell from livestock.</p></sec><sec id="s6"><title>Acknowledgements</title><p>This research was supported by the grants from the Scientific Research Foundation of Guangxi University [Grant No. XGZ130880], Guangxi Natural Science Foundation [Grant No. 2014GXNSFCB118003], and Chinese National Natural Science Foundation [Grant No. 31401267].</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.52959-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Nichols, J. and Smith, A. (2009) Naive and Primed Pluripotent States. Cell Stem Cell, 4, 487-492. http://dx.doi.org/10.1016/j.stem.2009.05.015</mixed-citation></ref><ref id="scirp.52959-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Gafni, O., Weinberger, L., Mansour, A.A., Manor, Y.S., Chomsky, E., Ben-Yosef, D., et al. (2013) Derivation of Novel Human Ground State Naive Pluripotent Stem Cells. Nature, 504, 282-286. http://dx.doi.org/10.1038/nature12745</mixed-citation></ref><ref id="scirp.52959-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Hassani, S.N., Totonchi, M., Gourabi, H., Scholer, H.R. and Baharvand, H. (2014) Signaling Roadmap Modulating Naive and Primed Pluripotency. Stem Cells and Development, 23, 193-208. http://dx.doi.org/10.1089/scd.2013.0368</mixed-citation></ref><ref id="scirp.52959-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Nowak-Imialek, M. and Niemann, H. (2013) Pluripotent Cells in Farm Animals: State of the Art and Future Perspectives. Reproduction Fertility and Development, 25, 103-128. http://dx.doi.org/10.1071/RD12265</mixed-citation></ref><ref id="scirp.52959-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, Y., Lin, J., Wang, L., Chen, B., Zhou, C., Chen, T., et al. (2011) Derivation and Characterization of Ovine Embryonic Stem-Like Cell Lines in Semi-Defined Medium without Feeder Cells. Journal of Experimental Zoology Part A, Ecological Genetics and Physiology, 315, 639-648. http://dx.doi.org/10.1002/jez.715</mixed-citation></ref><ref id="scirp.52959-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Liao, J., Cui, C., Chen, S., Ren, J., Chen, J., Gao, Y., et al. (2009) Generation of Induced Pluripotent Stem Cell Lines from Adult Rat Cells. Cell Stem Cell, 4, 11-15. http://dx.doi.org/10.1016/j.stem.2008.11.013</mixed-citation></ref><ref id="scirp.52959-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Huang, B., Li, T., Alonso-Gonzalez, L., Gorre, R., Keatley, S., Green, A., et al. (2011) A Virus-Free Poly-Promoter Vector Induces Pluripotency in Quiescent Bovine Cells under Chemically Defined Conditions of Dual Kinase Inhibition. PLoS One, 6, e24501. http://dx.doi.org/10.1371/journal.pone.0024501</mixed-citation></ref><ref id="scirp.52959-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Nagy, K., Sung, H.K., Zhang, P., Laflamme, S., Vincent, P., Agha-Mohammadi, S., et al. (2011) Induced Pluripotent Stem Cell Lines Derived from Equine Fibroblasts. Stem Cell Reviews, 7, 693-702. http://dx.doi.org/10.1007/s12015-011-9239-5</mixed-citation></ref><ref id="scirp.52959-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Deng, Y., Liu, Q., Luo, C., Chen, S., Li, X., Wang, C., et al. (2012) Generation of Induced Pluripotent Stem Cells From Buffalo [Bubalus bubalis] Fetal Fi-broblasts with Buffalo Defined Factors. Stem Cells and Development, 21, 2485-2494. http://dx.doi.org/10.1089/scd.2012.0018</mixed-citation></ref><ref id="scirp.52959-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Liu, J., Balehosur, D., Murray, B., Kelly, J.M., Sumer, H. and Verma, P.J. (2012) Generation and Characterization of Reprogrammed Sheep Induced Pluripotent Stem Cells. Theriogenology, 77, 338-346.http://dx.doi.org/10.1016/j.theriogenology.2011.08.006</mixed-citation></ref><ref id="scirp.52959-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Song, H., Li, H., Huang, M., Xu, D., Gu, C., Wang, Z., et al. (2013) Induced Pluripotent Stem Cells from Goat Fibroblasts. Molecular Reproduction and Development, 80, 1009-1017. http://dx.doi.org/10.1002/mrd.22266</mixed-citation></ref><ref id="scirp.52959-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">West, F.D., Uhl, E.W., Liu, Y., Stowe, H., Lu, Y., Yu, P., et al. (2011) Brief Report: Chimeric Pigs Produced from Induced Pluripotent Stem Cells Demonstrate Germline Transmission and No Evidence of Tumor Formation in Young Pigs. Stem Cells, 29, 1640-1643. http://dx.doi.org/10.1002/stem.713</mixed-citation></ref><ref id="scirp.52959-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Fan, N., Chen, J., Shang, Z., Dou, H., Ji, G., Zou, Q., et al. (2013) Piglets Cloned from Induced Pluripotent Stem Cells. Cell Research, 23, 162-166. http://dx.doi.org/10.1038/cr.2012.176</mixed-citation></ref><ref id="scirp.52959-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">McLaren, A. (2000) Cloning: Pathways to a Pluripotent Future. Science, 288, 1775-1780. http://dx.doi.org/10.1126/science.288.5472.1775</mixed-citation></ref><ref id="scirp.52959-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Do, J.T. and Scholer, H.R. (2004) Nuclei of Embryonic Stem Cells Reprogram Somatic Cells. Stem Cells, 22, 941-949. http://dx.doi.org/10.1634/stemcells.22-6-941</mixed-citation></ref><ref id="scirp.52959-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Takahashi, K. and Yamanaka, S. (2006) Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell, 126, 663-676. http://dx.doi.org/10.1016/j.cell.2006.07.024</mixed-citation></ref><ref id="scirp.52959-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007) Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell, 131, 861-872. http://dx.doi.org/10.1016/j.cell.2007.11.019</mixed-citation></ref><ref id="scirp.52959-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Hamanaka, S., Yamaguchi, T., Kobayashi, T., Kato-Itoh, M., Yamazaki, S., Sato, H., et al. (2011) Generation of Germline-Competent Rat Induced Pluripotent Stem Cells. PlOS One, 6, e22008. http://dx.doi.org/10.1371/journal.pone.0022008</mixed-citation></ref><ref id="scirp.52959-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Osteil, P., Tapponnier, Y., Markossian, S., Godet, M., Schmaltz-Panneau, B., Jouneau, L., et al. (2013) Induced Pluripotent Stem Cells Derived from Rabbits Exhibit Some Characteristics of Naive Pluripotency. Biology Open, 2, 613-628. http://dx.doi.org/10.1242/bio.20134242</mixed-citation></ref><ref id="scirp.52959-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Inoue, H., Nagata, N., Kurokawa, H. and Yamanaka, S. (2014) iPS Cells: A Game Changer for Future Medicine. The EMBO Journal, 33, 409-417. http://dx.doi.org/10.1002/embj.201387098</mixed-citation></ref><ref id="scirp.52959-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Suh, J.H., Kim, D., Kim, H., Helfman, D.M., Choi, J.H., Lee, B.H., et al. (2014) Modeling of Menkes Disease via Human Induced Pluripotent Stem Cells. Biochemical and Biophysical Research Communications, 444, 311-318. http://dx.doi.org/10.1016/j.bbrc.2014.01.038</mixed-citation></ref><ref id="scirp.52959-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Miao, X. (2013) Recent Advances in the Development of New Transgenic Animal Technology. Cellular and Molecular Life Sciences, 70, 815-828. http://dx.doi.org/10.1007/s00018-012-1081-7</mixed-citation></ref><ref id="scirp.52959-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., et al. (2007) Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells. Science, 318, 1917-1920. http://dx.doi.org/10.1126/science.1151526</mixed-citation></ref><ref id="scirp.52959-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A.E., et al. (2008) Induction of Pluripotent Stem Cells by Defined Factors Is Greatly Improved by Small-Molecule Compounds. Nature biotechnology, 26, 795-797. http://dx.doi.org/10.1038/nbt1418</mixed-citation></ref><ref id="scirp.52959-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. and Hochedlinger, K. (2008) Induced Pluripotent Stem Cells Generated without Viral Integration. Science, 322, 945-949. http://dx.doi.org/10.1126/science.1162494</mixed-citation></ref><ref id="scirp.52959-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Ma, K., Song, G., An, X., Fan, A., Tan, W., Tang, B., et al. (2014) miRNAs Promote Generation of Porcine-Induced Pluripotent Stem Cells. Molecular and Cellular Biochemistry, 389, 209-218 http://dx.doi.org/10.1007/s11010-013-1942-x</mixed-citation></ref><ref id="scirp.52959-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Kim, D., Kim, C.H., Moon, J.I., Chung, Y.G., Chang, M.Y., Han, B.S., et al. (2009) Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Re-programming Proteins. Cell Stem Cell, 4, 472-476. http://dx.doi.org/10.1016/j.stem.2009.05.005</mixed-citation></ref><ref id="scirp.52959-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., et al. (2013) Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds. Science, 341, 651-654. http://dx.doi.org/10.1126/science.1239278</mixed-citation></ref><ref id="scirp.52959-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Su, J.B., Pei, D.Q. and Qin, B.M. (2013) Roles of Small Molecules in Somatic Cell Reprogramming. Acta Pharmacologica Sinica, 34, 719-724. http://dx.doi.org/10.1038/aps.2013.73</mixed-citation></ref><ref id="scirp.52959-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Jung, D.W., Kim, W.H. and Williams, D.R. (2014) Reprogram or Reboot: Small Molecule Approaches for the Production of Induced Pluripotent Stem Cells and Direct Cell Reprogramming. ACS Chemical Biology, 9, 80-95. http://dx.doi.org/10.1021/cb400754f</mixed-citation></ref><ref id="scirp.52959-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Li, W., Jiang, K., Wei, W., Shi, Y. and Ding, S. (2013) Chemical Approaches to Studying Stem Cell Biology. Cell Research, 23, 81-91. http://dx.doi.org/10.1038/cr.2012.182</mixed-citation></ref><ref id="scirp.52959-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Li, W., Wei, W., Zhu, S., Zhu, J., Shi, Y., Lin, T., et al. (2009) Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors. Cell Stem Cell, 4, 16-19. http://dx.doi.org/10.1016/j.stem.2008.11.014</mixed-citation></ref><ref id="scirp.52959-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Lin, T., Ambasudhan, R., Yuan, X., Li, W., Hilcove, S., Abujarour, R., et al. (2009) A Chemical Platform for Improved Induction of Human iPSCs. Nature Methods, 6, 805-808. http://dx.doi.org/10.1038/nmeth.1393</mixed-citation></ref><ref id="scirp.52959-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Gross, B., Sgodda, M., Rasche, M., Schambach, A., Gohring, G., Schlegelberger, B., et al. (2013) Improved Generation of Patient-Specific Induced Pluripotent Stem Cells Using a Chemically-Defined and Matrigel-Based Approach. Current Molecular Medicine, 13, 765-776. http://dx.doi.org/10.2174/1566524011313050008</mixed-citation></ref><ref id="scirp.52959-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Grace, A., McMillan, M., Schmoelzl, S. and Hinch, G. (2013) 187 Increased Efficiency of Deriving Bovine Stem Cell-Like Colonies Using Valproic Acid and Small Molecule Cocktails. Reproduction, Fertility and Development, 26, 208. http://dx.doi.org/10.1071/RDv26n1Ab187</mixed-citation></ref><ref id="scirp.52959-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Shi, Y., Desponts, C., Do, J.T., Hahm, H.S., Scholer, H.R. and Ding, S. (2008) Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds. Cell Stem Cell, 3, 568-774. http://dx.doi.org/10.1016/j.stem.2008.10.004</mixed-citation></ref><ref id="scirp.52959-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Zhu, S., Li, W., Zhou, H., Wei, W., Ambasudhan, R., Lin, T., et al. (2010) Reprogramming of Human Primary Somatic Cells by OCT4 and Chemical Compounds. Cell Stem Cell, 7, 651-655. http://dx.doi.org/10.1016/j.stem.2010.11.015</mixed-citation></ref><ref id="scirp.52959-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Trokovic, R., Weltner, J., Manninen, T., Mikkola, M., Lundin, K., Hamalainen, R., et al. (2013) Small Molecule Inhibitors Promote Efficient Generation of Induced Pluripotent Stem Cells from Human Skeletal Myoblasts. Stem Cells and Development, 22, 114-123. http://dx.doi.org/10.1089/scd.2012.0157</mixed-citation></ref><ref id="scirp.52959-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Q., Xu, X., Li, J., Liu, J., Gu, H., Zhang, R., et al. (2011) Lithium, an Anti-Psychotic Drug, Greatly Enhances the Generation of Induced Pluripotent Stem Cells. Cell Research, 21, 1424-1435. http://dx.doi.org/10.1038/cr.2011.108</mixed-citation></ref><ref id="scirp.52959-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Xu, X., Wang, Q., Long, Y., Zhang, R., Wei, X., Xing, M., et al. (2013) Stress-Mediated p38 Activation Promotes Somatic Cell Reprogramming. Cell Research, 23, 131-141. http://dx.doi.org/10.1038/cr.2012.143</mixed-citation></ref><ref id="scirp.52959-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Wei, X., Chen, Y., Xu, Y., Zhan, Y., Zhang, R., Wang, M., et al. (2014) Small Molecule Compound Induces Chromatin De-Condensation and Facilitates Induced Pluripotent Stem Cell Generation. Journal of Molecular Cell Biology, 6, 409-420. http://dx.doi.org/10.1093/jmcb/mju024</mixed-citation></ref><ref id="scirp.52959-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Ichida, J.K., Blanchard, J., Lam, K., Son, E.Y., Chung, J.E., Egli, D., et al. (2009) A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog. Cell Stem Cell, 5, 491-503. http://dx.doi.org/10.1016/j.stem.2009.09.012</mixed-citation></ref><ref id="scirp.52959-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Staerk, J., Lyssiotis, C.A., Medeiro, L.A., Bollong, M., Foreman, R.K., Zhu, S., et al. (2011) Pan-Src Family Kinase Inhibitors Replace Sox2 during the Direct Reprogramming of Somatic Cells. Angewandte Chemie International Edition, 50, 5734-5736. http://dx.doi.org/10.1002/anie.201101042</mixed-citation></ref><ref id="scirp.52959-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Lyssiotis, C.A., Foreman, R.K., Staerk, J., Garcia, M., Mathur, D., Markoulaki, S., et al. (2009) Reprogramming of Murine Fibroblasts to Induced Pluripotent Stem Cells with Chemical Complementation of Klf4. Proceedings of the National Academy of Sciences, 106, 8912-8917. http://dx.doi.org/10.1073/pnas.0903860106</mixed-citation></ref><ref id="scirp.52959-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., et al. (2008) Induction of Pluripotent Stem Cells from Primary Human Fibroblasts with Only Oct4 and Sox2. Nature Biotechnology, 26, 1269-1275. http://dx.doi.org/10.1038/nbt.1502</mixed-citation></ref><ref id="scirp.52959-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Sui, D., Sun, Z., Xu, C., Wu, Y., Capecchi, M.R., Wu, S., et al. (2014) Fine-Tuning of iPSC Derivation by an Inducible Reprogramming System at the Protein Level. Stem Cell Reports, 2, 21-33. http://dx.doi.org/10.1016/j.stemcr.2014.03.013</mixed-citation></ref><ref id="scirp.52959-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Li, Y., Zhang, Q., Yin, X., Yang, W., Du, Y., Hou, P., et al. (2011) Generation of iPSCs from Mouse Fibroblasts with a Single Gene, Oct4, and Small Molecules. Cell Research, 21, 196-204. http://dx.doi.org/10.1038/cr.2010.142</mixed-citation></ref><ref id="scirp.52959-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Yuan, X., Wan, H., Zhao, X., Zhu, S., Zhou, Q. and Ding, S. (2011) Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts. Stem Cells, 29, 549-553. http://dx.doi.org/10.1002/stem.594</mixed-citation></ref><ref id="scirp.52959-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Kang, P.J., Moon, J.H., Yoon, B.S., Hyeon, S., Jun, E.K., Park, G., et al. (2014) Reprogramming of Mouse Somatic Cells into Pluripotent Stem-Like Cells Using a Combination of Small Molecules. Biomaterials, 35, 336-345. http://dx.doi.org/10.1016/j.biomaterials.2014.05.015</mixed-citation></ref><ref id="scirp.52959-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Ying, Q.L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., et al. (2008) The Ground State of Embryonic Stem Cell Self-Renewal. Nature, 453, 519-523. http://dx.doi.org/10.1038/nature06968</mixed-citation></ref><ref id="scirp.52959-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Hirano, K., Nagata, S., Yamaguchi, S., Nakagawa, M., Okita, K., Kotera, H., et al. (2012) Human and Mouse Induced Pluripotent Stem Cells Are Differentially Reprogrammed in Response to Kinase Inhibitors. Stem Cells and Development, 21, 1287-1298. http://dx.doi.org/10.1089/scd.2011.0283</mixed-citation></ref><ref id="scirp.52959-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Leitch, H.G., McEwen, K.R., Turp, A., Encheva, V., Carroll, T., Grabole, N., et al. (2013) Naive Pluripotency Is Associated with Global DNA Hypomethylation. Nature Structural &amp; Molecular Biology, 20, 311-316. http://dx.doi.org/10.1038/nsmb.2510</mixed-citation></ref><ref id="scirp.52959-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Yamaji, M., Ueda, J., Hayashi, K., Ohta, H., Yabuta, Y., Kurimoto, K., et al. (2013) PRDM14 Ensures Naive Pluripotency through Dual Regulation of Signaling and Epigenetic Pathways in Mouse Embryonic Stem Cells. Cell Stem Cell, 12, 368-382. http://dx.doi.org/10.1016/j.stem.2012.12.012</mixed-citation></ref><ref id="scirp.52959-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Buehr, M., Meek, S., Blair, K., Yang, J., Ure, J., Silva, J., et al. (2008) Capture of Authentic Embryonic Stem Cells from Rat Blastocysts. Cell, 135, 1287-1298. http://dx.doi.org/10.1016/j.cell.2008.12.007</mixed-citation></ref><ref id="scirp.52959-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Li, P., Tong, C., Mehrian-Shai, R., Jia, L., Wu, N., Yan, Y., et al. (2008) Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts. Cell, 135, 1299-1310. http://dx.doi.org/10.1016/j.cell.2008.12.006</mixed-citation></ref><ref id="scirp.52959-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">Leitch, H.G., Blair, K., Mansfield, W., Ayetey, H., Humphreys, P., Nichols, J., et al. (2010) Embryonic Germ Cells from Mice and Rats Exhibit Properties Consistent with a Generic Pluripotent Ground State. Development, 137, 2279-2287. http://dx.doi.org/10.1242/dev.050427</mixed-citation></ref><ref id="scirp.52959-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">Blair, K., Leitch, H.G., Mansfield, W., Dumeau, C.E., Humphreys, P. and Smith, A.G. (2012) Culture Parameters for Stable Expansion, Genetic Modification and Germline Transmission of Rat Pluripotent Stem Cells. Biology Open, 1, 58-65. http://dx.doi.org/10.1242/bio.2011029</mixed-citation></ref><ref id="scirp.52959-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Ten Berge, D., Kurek, D., Blauwkamp, T., Koole, W., Maas, A., Eroglu, E., et al. (2011) Embryonic Stem Cells Require Wnt Proteins to Prevent Differentiation to Epiblast Stem Cells. Nature Cell Biology, 13, 1070-1075. http://dx.doi.org/10.1038/ncb2314</mixed-citation></ref><ref id="scirp.52959-ref59"><label>59</label><mixed-citation publication-type="other" xlink:type="simple">Kinehara, M., Kawamura, S., Tateyama, D., Suga, M., Matsumura, H., Mimura, S., et al. (2013) Protein Kinase C Regulates Human Pluripotent Stem Cell Self-Renewal. PlOS One, 8, e54122. http://dx.doi.org/10.1371/journal.pone.0054122</mixed-citation></ref><ref id="scirp.52959-ref60"><label>60</label><mixed-citation publication-type="other" xlink:type="simple">Zhou, H., Li, W., Zhu, S., Joo, J.Y, Do, J.T., Xiong, W., et al. (2010) Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules. Journal of Biological Chemistry, 285, 29676-29680. http://dx.doi.org/10.1074/jbc.C110.150599</mixed-citation></ref><ref id="scirp.52959-ref61"><label>61</label><mixed-citation publication-type="other" xlink:type="simple">Kang, S.J., Park, Y.I., So, B. and Kang, H.G. (2014) Sodium Butyrate Efficiently Converts Fully Reprogrammed Induced Pluripotent Stem Cells from Mouse Partially Reprogrammed Cells. Cellular Reprogramming, 16, 345-354. http://dx.doi.org/10.1089/cell.2013.0087</mixed-citation></ref><ref id="scirp.52959-ref62"><label>62</label><mixed-citation publication-type="other" xlink:type="simple">Baharvand, H. and Hassani, S.N. (2013) A New Chemical Approach to the Efficient Generation of Mouse Embryonic Stem Cells. Methods in Molecular Biology, 997, 13-22. http://dx.doi.org/10.1007/978-1-62703-348-0_2</mixed-citation></ref><ref id="scirp.52959-ref63"><label>63</label><mixed-citation publication-type="other" xlink:type="simple">Rodriguez, A., Allegrucci, C. and Alberio, R. (2012) Modulation of Pluripotency in the Porcine Embryo and iPS Cells. PLOS One, 7, e49079. http://dx.doi.org/10.1371/journal.pone.0049079</mixed-citation></ref><ref id="scirp.52959-ref64"><label>64</label><mixed-citation publication-type="other" xlink:type="simple">Gao, Y., Guo, Y., Duan, A., Cheng, D., Zhang, S. and Wang, H. (2014) Optimization of Culture Conditions for Maintaining Porcine Induced Pluripotent Stem Cells. DNA and Cell Biology, 33, 1-11. http://dx.doi.org/10.1089/dna.2013.2095</mixed-citation></ref><ref id="scirp.52959-ref65"><label>65</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Y., Wei, C., Zhang, P., Li, X., Liu, T., Pu, Y., et al. (2014) Efficient Reprogramming of Naive-Like Induced Pluripotent Stem Cells from Porcine Adipose-Derived Stem Cells with a Feeder-Independent and Serum-Free System. PLOS One, 9, e85089. http://dx.doi.org/10.1371/journal.pone.0085089</mixed-citation></ref><ref id="scirp.52959-ref66"><label>66</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, R., George, A., Kamble, N.M., Singh, K.P., Chauhan, M.S., Singla, S.K., et al. (2011) Optimization of Culture Conditions to Support Long-Term Self-Renewal of Buffalo (Bubalus bubalis) Embryonic Stem Cell-Like Cells. Cell Reprogramming, 13, 539-549.</mixed-citation></ref><ref id="scirp.52959-ref67"><label>67</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, R., George, A., Chauhan, M.S., Singla, S., Manik, R.S. and Palta, P. (2013) ROCK Inhibitor Y-27632 Enhances the Survivability of Dissociated Buffalo (Bubalus bubalis) Embryonic Stem Cell-Like Cells. Reproduction, Fertility and Development, 25, 446-455. http://dx.doi.org/10.1071/RD11315</mixed-citation></ref><ref id="scirp.52959-ref68"><label>68</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, R., Kamble, N.M., George, A., Chauhan, M.S., Singla, S., Manik, R.S., et al. (2013) Effect of TGF-β1 Superfamily Members on Survival of Buffalo (Bubalus bubalis) Embryonic Stem-Like Cells. Reproduction in Domestic Animals, 48, 569-576. http://dx.doi.org/10.1111/rda.12126</mixed-citation></ref><ref id="scirp.52959-ref69"><label>69</label><mixed-citation publication-type="other" xlink:type="simple">Harris, D., Huang, B. and Oback, B. (2013) Inhibition of MAP2K and GSK3 Signaling Promotes Bovine Blastocyst Development and Epiblast-Associated Expression of Pluripotency Factors. Biology of Reproduction, 88, 74. http://dx.doi.org/10.1095/biolreprod.112.103390</mixed-citation></ref><ref id="scirp.52959-ref70"><label>70</label><mixed-citation publication-type="other" xlink:type="simple">Verma, V., Huang, B., Kallingappa, P.K. and Oback, B. (2013) Dual Kinase Inhibition Promotes Pluripotency in Finite Bovine Embryonic Cell Lines. Stem Cells and Development, 22, 1728-1742. http://dx.doi.org/10.1089/scd.2012.0481</mixed-citation></ref><ref id="scirp.52959-ref71"><label>71</label><mixed-citation publication-type="other" xlink:type="simple">Lu, F., Lao, Y., Sun, H., Lei, C., Deng, Y., Luo, C., et al. (2013) 195 Effects of Gsk3 Inhibitor on the Pluripotency Maintenance of Buffalo Embryonic Stem-Cell-Like Cells. Reproduction, Fertility and Development, 26, 212. http://dx.doi.org/10.1071/RDv26n1Ab195</mixed-citation></ref></ref-list></back></article>